Is Cannabis the Solution to the Chronic Pain Crisis?

Insights

20 Dec 2019

Doctor hand holding cannabis and pills
Study conducted by Southern Cannabis Holdings (SCH) has found that medicinal cannabis may be a highly effective treatment for chronic pain

A new study has found that medicinal cannabis may be able to reduce the intensity of chronic pain in patients by as much as 30%.

A new study conducted by Southern Cannabis Holdings (SCH) has found that medicinal cannabis may be a highly effective treatment option for patients suffering from chronic pain.

The study was carried out by Applied Cannabis Research—which is a division of SCH—in partnership with Little Green Pharma (LGP), the first Australian producer of locally-grown and GMP-manufactured cannabis products.

This is in keeping with LGP's ongoing business strategy, which centres on improving patient access through education and supporting the market with cannabis grown at the company's secure facility in Western Australia.

Applied Cannabis Research chose to focus on chronic pain patients who have exhausted conventional forms of therapy for the study, which is currently recruiting an additional 300 patients over the age of 25 via the Cannabis Access Clinics' healthcare network.

Initial findings from the study—which makes uses of Little Green Pharma products—have demonstrated a trend in patients towards improvements in pain, anxiety, sleep disturbance, depression, and other quality of life measures.

For the full media release and to read more about this research, please visit: https://thegreenfund.com/is-cannabis-the-answer-to-the-chronic-pain-crisis

You might also be interested in

Greenchpices

Company news

GreenChoices launches

Little Green Pharma have sponsored a new digital platform, GreenChoices to provide both medical practitioners and patients with meaningful research and education, with the aim of assisting them make informed choices about medical cannabis as a possible treatment option.

Aug 2018

Fleta Solomon MD green polo

Insights

Big plans for Little Green Pharma

Read more on the Australian firm hoping to help more UK patients benefit from medical cannabis.

Apr 2020

Littlegreenpharma image

Insights

Little Green Pharma blazes onto the ASX

Australia's latest listed medicinal cannabis company has launched onto the market with a bang, scoring a major UK distribution deal the night before landing.

Feb 2020

View all articles